Intercept Pharma (ICPT) Tops Q1 EPS by 64c
Get Alerts ICPT Hot Sheet
Join SI Premium – FREE
Intercept Pharma (NASDAQ: ICPT) reported Q1 EPS of ($3.61), $0.64 better than the analyst estimate of ($4.25). Revenue for the quarter came in at $21 million versus the consensus estimate of $15.8 million.
For earnings history and earnings-related data on Intercept Pharma (ICPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Brandywine Realty Trust (BDN) Reports In-Line Q1 EPS, provides guidance
- Logansport Financial Corp. (LOGN) Reports Q1 EPS of $0.44
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!